Zidovudine Suppliers & Bulk Manufacturers
Available Forms: Capsules, Tablet and Oral solution
Available Strengths: Capsules: 100 mg, 250 mg, 300mg; Tab: 300 mg; Oral Sol: 10 mg/ ml
Reference Brands: Retrovir®(Us & EU)
Category:
Anti Viral
Zidovudine Capsules (100–300 mg), branded as Retrovir® or Zidovir®, are essential NRTIs used in HIV-1 treatment and prevention. Available from WHO-GMP suppliers on PharmaB2B, Zidovudine supports HIV care in low-resource settings, tenders, and maternal transmission prevention programs.
Zidovudine is available in Capsules, Tablet and Oral solution
and strengths such as Capsules: 100 mg, 250 mg, 300mg; Tab: 300 mg; Oral Sol: 10 mg/ ml.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Zidovudine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Zidovudine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Zidovudine Capsules (AZT), sold under brands like Retrovir® and Zidovir®, are a cornerstone NRTI antiretroviral used in the treatment and prevention of HIV-1 infection. Available in 100 mg to 300 mg strengths, Zidovudine is vital in adult and pediatric regimens and remains widely used in low-resource settings, PMTCT (Prevention of Mother-to-Child Transmission), and post-exposure prophylaxis. On PharmaB2B platforms, healthcare organizations can source WHO-GMP and USFDA-approved Zidovudine in bulk from trusted manufacturers for tenders and global health programs. Cost-effective and clinically proven, Zidovudine continues to play a key role in global HIV/AIDS control strategies.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing